pH Gradient Buffer System for LC-MS Antibody Analysis

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for monitoring post-translational modifications (PTMs) in monoclonal antibodies using ion-exchange chromatography coupled with high-resolution mass spectrometry face challenges such as non-linearity of pH gradients, poor chromatographic reproducibility, and reduced mass spectrometric resolution due to high charge states of intact proteins.

Innovation Solution

The development of pH gradient mobile phase buffer compositions with low ionic strength and optimized pH control, using ammonium acetate and N-methylmorpholine, which improve MS sensitivity and resolution by providing more-native mass spectra for intact proteins, enhancing chromatographic resolution of charge variants of monoclonal antibodies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional buffer systems are used for IEC-HRMS analysis, then pH gradient elution can be achieved, but pH gradient linearity and chromatographic reproducibility deteriorate

Engineering Contradiction:

Improvechromatographic reproducibilityVSAvoidpH gradient linearity

Core Design Contradiction:

ReliabilityVSManufacturing precision

Solution Approach 1:

The patent changes the chemical composition parameters of the buffer system by replacing conventional buffers (ammonium bicarbonate, triethylamine) with a novel combination of ammonium formate and N-methylmorpholine. This parameter change resolves the contradiction by providing a buffer system that simultaneously achieves linear pH gradients and high chromatographic reproducibility, as demonstrated by consistent retention times and well-resolved charge variants across multiple runs.

Inventive Principle:

Principle #35Parameter changes

2Measurement precision

If high salt concentration buffers are used, then pH control is improved, but mass spectrometric sensitivity and resolution deteriorate

Engineering Contradiction:

Improvemass spectrometric resolutionVSAvoidpH control

Core Design Contradiction:

Measurement precisionVSReliability

Solution Approach 1:

The patent changes the ionic strength parameter by using low-concentration buffer components (ammonium formate and N-methylmorpholine at concentrations typically below 50 mM). This resolves the contradiction by maintaining sufficient pH control for gradient elution while keeping salt concentration low enough to avoid suppressing ionization in the mass spectrometer, thereby achieving both good pH control and high MS sensitivity with clear charge state envelopes.

Inventive Principle:

Principle #35Parameter changes

3Measurement precision

If conventional buffer compositions are used, then chromatographic elution can be achieved, but MS sensitivity and native protein spectrum quality deteriorate

Engineering Contradiction:

ImproveMS sensitivityVSAvoidchromatographic elution effectiveness

Core Design Contradiction:

Measurement precisionVSEase of operation

Solution Approach 1:

The patent introduces N-methylmorpholine as an intermediary buffer component that mediates between the requirements of chromatographic elution and mass spectrometric detection. This compound provides effective pH gradient formation for protein elution while being sufficiently volatile and low-ionic-strength to be compatible with native MS, thereby resolving the contradiction between chromatographic effectiveness and MS sensitivity.

Inventive Principle:

Principle #24Intermediary (Mediator)

4Manufacturing precision

If standard buffer systems are used, then protein elution can be achieved, but charge variant resolution and pH linearity deteriorate

Engineering Contradiction:

Improvecharge variant resolutionVSAvoidbuffer composition complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent creates a composite buffer system by combining ammonium formate and N-methylmorpholine in specific ratios. This composite approach resolves the contradiction by achieving superior charge variant resolution and pH gradient linearity through the synergistic interaction of the two components, while the relative simplicity of the two-component system keeps the overall complexity manageable.

Inventive Principle:

Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution achieves improved pH control, increased MS sensitivity, and higher mass spectral resolution, effectively addressing the limitations of existing methods by providing better chromatographic and mass spectrometric resolution of charge variants, critical for the characterization of monoclonal antibodies.

Implementation Method 1

giving good pH control across a wide range of pH values (pH 5.2-10.2)

Methodology Applied

Scientific EffectpH gradient control:

Implementation Method 2

with low ionic strength (≤ ~50 mM, ≤ ~30 mM, or ≤ ~20 mM) and with the advantages of giving improved MS sensitivity

Methodology Applied

Scientific EffectIon suppression reduction:

Implementation Method 3

ion-exchange chromatography (IEC) with ultraviolet monitoring (UV) using a salt or pH gradient for elution

Methodology Applied

Scientific EffectIon exchange: Ion Exchange

Implementation Method 4

Monitoring mAb PTMs with IEC coupled to native high-resolution mass spectrometry (HRMS) allows for rapid identification of modifications

Methodology Applied

Scientific EffectMass spectrometry:

Data Source

PatentUS20240393298A1Mass spectrometry-compatible ph gradient buffer system

Publication Date: 2024.11.28 PHENOMENEX INC

AI summary

Improved mobile phase buffer compositions, methods, and kits are provided for pH gradient LC-MS characterization of monoclonal antibodies and charge variants thereof.